Imagine a game of chess where your opponent's king is in check. It cannot move, but the game is not over—the piece remains on ...

Findings identify genes that may represent possible new targets for a "block and lock" strategy for curing HIV.

An immune response that likely evolved to help fight infections appears to be the mechanism that drives human immunodeficiency virus (HIV) into a latent state, lurking in cells only to erupt anew, ...

For millions of people living with HIV, a daily regimen of medications is a lifelong necessity. If they stop taking the drugs ...

A dual-action HIV antibody–drug conjugate forces Env to open, then blocks it, boosting virus neutralization up to tenfold in ...

HIV-1 protease inhibitors (PIs) have long been central to antiretroviral therapy, directly targeting the enzyme responsible for processing viral polyproteins into functional units. Their efficacy, ...

HIV have complex weapons of attack while the invaded T cells have intricate defence mechanisms that are still far from being completely understood. Three papers in November, Nature Medicine show new ...

Researchers at the German Center for Infection Research (DZIF) at Heidelberg University Hospital have decoded a previously unknown mechanism by which HIV-1 selects its integration targets in the human ...

The 5th International Workshop on HIV Drug Resistance and Treatment Strategies was held in Scottsdale, Arizona, June 4-8, 2001. Two hundred and fifty delegates gathered in the Sonoran Desert to listen ...

For all that is known about human immunodeficiency virus (HIV), some remarkably fundamental questions remain. One of the most notable, perhaps, is just how HIV manages to infect its primary target, ...

HIV, originating from chimpanzees, has evolved from a deadly diagnosis to a manageable chronic condition thanks to ...